Who invested in Aspyrian Therapeutics?
Aspyrian Therapeutics's investors include Hiroshi Mikitani.
United States · Series B startup
3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 3 rounds since 2015, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $4.2M sold, first sale Jul 2015
No investor was named in the report.
From a historical funding recordSEC filing: $8.5M sold, first sale Dec 2014
From the SEC filings it signed: 2 on the team.
On the board, as filediHiroshi MikitaniHiroshi Mori
Aspyrian Therapeutics's investors include Hiroshi Mikitani.
Aspyrian Therapeutics has raised $28M across 3 rounds since 2015.
Aspyrian Therapeutics's most recent round was a Series B of $15M in Jul 2017.
Its most recent round, $15M in Jul 2017, is also its largest on record.
Aspyrian Therapeutics's first round on record, in Jul 2017, was backed by Hiroshi Mikitani.
Aspyrian Therapeutics's latest named round is a Series B, in Jul 2017.
Aspyrian Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.